Primary Site >> Liver Cancer

Gene >> CD22

Journal: Gastroenterol Clin Biol. 1989 Apr;13(4):343-52.
Title: [Immunochemical diagnosis of hepatic localizations in malignant lymphoid hematologic diseases. Study of 80 cases].
Author: Voigt, J J|Vinel, J P|Caveriviere, P|Pradere, B|Chittal, S|al Saati, T|Cales, P|Delsol, G
PMID: 2661293
Journal: Am J Surg Pathol. 1998 Dec;22(12):1528-37.
Title: Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature.
Author: Ichinohasama, R|Miura, I|Kobayashi, N|Saitoh, Y|DeCoteau, J F|Saiki, Y|Mori, S|Kadin, M E|Ooya, K
PMID: 9850179
Journal: Lab Invest. 2002 Nov;82(11):1515-24.
Title: Differential expression of beta-galactoside alpha2,6 sialyltransferase and sialoglycans in normal and cirrhotic liver and hepatocellular carcinoma.
Author: Cao, Yi|Merling, Anette|Crocker, Paul R|Keller, Ruprecht|Schwartz-Albiez, Reinhard
PMID: 12429811
Journal: Biosci Rep. 2018 Oct 24. pii: BSR20181423.
Title: Downregulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus.
Author: Ren, Xiaojing|Ji, Yuanyuan|Jiang, Xuhua|Qi, Xun
PMID: 30355653